2190
HKSE:2190
Zylox-Tonbridge Medical Technology Co., Ltd.
- Stock
Last Close
11.14
30/08 08:08
Market Cap
3.51B
Beta: -
Volume Today
584K
Avg: 340.27K
PE Ratio
−24.10
PFCF: −12.34
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -34.86M - | -34.86M 0% | -64.99M 86.43% | -64.99M 0% | -12.75M 80.38% | -12.75M 0% | -44.03M 245.24% | -44.03M 0% | -17.76M 59.67% | -17.76M 0% | -21.61M 21.70% | -21.61M 0% | |
depreciation and amortization | 2.82M - | 2.82M 0% | 3.87M 37.10% | 3.87M 0% | 5.68M 46.82% | 5.68M 0% | 7.25M 27.58% | 7.25M 0% | 8.18M 12.94% | 8.18M 0% | |||
deferred income tax | 4.51M - | -28.02M 721.77% | |||||||||||
stock based compensation | 11.23M - | 11.23M 0% | 26.88M 139.39% | 26.88M 0% | 17.07M 36.48% | 17.07M 0% | 26.77M 56.78% | 26.77M 0% | 15.00M 43.97% | 15.00M 0% | 27.89M 85.97% | 27.89M 0% | |
change in working capital | -20.86M - | -20.86M 0% | -31.27M - | -31.27M 0% | |||||||||
accounts receivables | -164.50K - | -164.50K 0% | -287K - | -287K 0% | |||||||||
inventory | -14.14M - | -14.14M 0% | -30.99M - | -30.99M 0% | |||||||||
accounts payables | |||||||||||||
other working capital | -6.55M - | -6.55M 0% | |||||||||||
other non cash items | -1.53M - | -1.53M 0% | 19.33M 1,367.03% | 19.33M 0% | -35.08M 281.51% | -35.08M 0% | 16.20M 146.17% | 48.73M 200.78% | -14.69M 130.14% | -14.69M 0% | -6.28M 57.25% | -6.28M 0% | |
net cash provided by operating activities | -22.33M - | -22.33M 0% | -35.77M 60.15% | -35.77M 0% | -25.08M 29.87% | -25.08M 0% | -20.58M 17.96% | -20.58M 0% | -9.26M 54.99% | -9.26M 0% | |||
investments in property plant and equipment | -16.48M - | -16.48M 0% | -22.57M 36.96% | -22.57M 0% | -34.51M 52.88% | -34.51M 0% | -32.86M 4.79% | -32.86M 0% | -57.25M 74.23% | -57.25M 0% | |||
acquisitions net | -130.57M - | 30.54K - | |||||||||||
purchases of investments | -1.87B - | -572.85M - | |||||||||||
sales maturities of investments | 2.19B - | 818.84M - | |||||||||||
other investing activites | -209.03M - | -209.03M 0% | -416.09M 99.05% | -416.09M 0% | -110.73M 73.39% | -110.73M 0% | 130.57M 217.92% | -62.64M 147.97% | 112.75M 280.01% | -133.27M 218.19% | |||
net cash used for investing activites | -225.51M - | -225.51M 0% | -438.66M 94.52% | -438.66M 0% | -145.24M 66.89% | -145.24M 0% | 97.72M 167.28% | 97.72M 0% | 55.51M 43.20% | 55.51M 0% | |||
debt repayment | -10.18M - | ||||||||||||
common stock issued | 1.05M - | ||||||||||||
common stock repurchased | -4.57M - | -4.57M 0% | -11.36M 148.32% | -11.36M 0% | -962.50K 91.53% | -962.50K 0% | -62.50K 93.51% | -62.50K 0% | |||||
dividends paid | |||||||||||||
other financing activites | 238.60M - | 238.60M 0% | 1.17B 390.72% | 1.17B 0% | -2.08M 100.18% | -13.44M 545.61% | -724.50K 94.61% | -1.78M 145.00% | 2.59M 245.66% | 12.76M 393.68% | |||
net cash used provided by financing activities | 238.60M - | 238.60M 0% | 1.17B 388.81% | 1.17B 0% | -13.44M 101.15% | -13.44M 0% | -1.69M 87.45% | -1.69M 0% | 2.52M 249.56% | 2.52M 0% | |||
effect of forex changes on cash | 23.50K - | 23.50K 0% | -3.25M 13,951.06% | -3.25M 0% | 3.13M 196.04% | 3.13M 0% | -1.34M 142.93% | -1.34M 0% | 2.02M 250.52% | 2.02M 0% | |||
net change in cash | -9.22M - | -9.22M 0% | 688.62M 7,566.78% | 688.62M 0% | -180.64M 126.23% | -180.64M 0% | 74.11M 141.03% | 114.87M 55.00% | 50.79M 55.79% | 56.80M 11.83% | |||
cash at beginning of period | 50.33M - | 41.11M 18.32% | 1.24B - | 1.06B 14.59% | 1.24B 17.22% | 1.35B - | |||||||
cash at end of period | -9.22M - | 41.11M 545.77% | 729.74M 1,675.04% | 688.62M 5.63% | -180.64M 126.23% | 1.06B 685.20% | 1.13B 7.01% | 1.35B 19.69% | 50.79M 96.25% | 1.41B 2,677.83% | |||
operating cash flow | -22.33M - | -22.33M 0% | -35.77M 60.15% | -35.77M 0% | -25.08M 29.87% | -25.08M 0% | -20.58M 17.96% | -20.58M 0% | -9.26M 54.99% | -9.26M 0% | |||
capital expenditure | -16.48M - | -16.48M 0% | -22.57M 36.96% | -22.57M 0% | -34.51M 52.88% | -34.51M 0% | -32.86M 4.79% | -32.86M 0% | -57.25M 74.23% | -57.25M 0% | |||
free cash flow | -38.82M - | -38.82M 0% | -58.34M 50.30% | -58.34M 0% | -59.59M 2.14% | -59.59M 0% | -53.44M 10.33% | -53.44M 0% | -66.51M 24.47% | -66.51M 0% |
All numbers in HKD (except ratios and percentages)